2017. Safety and Efficacy of Apremilast Through 104 Weeks in Patients swith Moderate-to-Severe Psoriasis Who Continued on Apremilast or Switched from Etanercept Treatment in the LIBERATE Study. SKIN The Journal of Cutaneous Medicine. 1, 3.1 (Oct. 2017), s32. DOI:https://doi.org/10.25251/skin.1.supp.31.